We are live on ! Find out more
GC

Gratus Capital Portfolio holdings

AUM $2.5B
1-Year Est. Return 32.89%
This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+32.89%
3 Year Est. Return
+51.43%
5 Year Est. Return
+136.95%
10 Year Est. Return
AUM
$700M
AUM Growth
+$5.58M
Cap. Flow
-$15.5M
Cap. Flow %
-2.22%
Top 10 Hldgs %
43.97%
Holding
187
New
11
Increased
47
Reduced
46
Closed
3

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$5.09M
2
EW icon
Edwards Lifesciences
EW
+$2.4M
3
SYY icon
Sysco
SYY
+$1.88M
4
INTC icon
Intel
INTC
+$1.77M
5
UHAL icon
U-Haul Holding Co
UHAL
+$1.26M

Sector Composition

Rank Sector Weight
1 Consumer Staples 33.15%
2 Industrials 11.32%
3 Healthcare 10.36%
4 Financials 9.23%
5 Technology 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLG
176
Flagstar Bank National Association
FLG
$5.77B
$144K 0.02%
3,667
DNP icon
177
DNP Select Income Fund
DNP
$4.18B
$139K 0.02%
+12,647
New +$139K
OPK icon
178
Opko Health
OPK
$921M
$110K 0.02%
16,775
STRM
179
DELISTED
Streamline Health Solutions
STRM
$92K 0.01%
5,721
CDI
180
DELISTED
CDI Corp.
CDI
$75K 0.01%
12,830
ABEV icon
181
Ambev
ABEV
$47.3B
$69K 0.01%
12,500
PDLI
182
DELISTED
PDL BioPharma, Inc.
PDLI
$32K ﹤0.01%
13,000
ATHX
183
DELISTED
Athersys, Inc. Common Stock
ATHX
$15K ﹤0.01%
400
VNQ icon
184
Vanguard Real Estate ETF
VNQ
$39.9B
-17,311
Closed -$1.43M
MMP
185
DELISTED
Magellan Midstream Partners, L.P.
MMP
-2,732
Closed -$210K
VAL
186
DELISTED
Valspar
VAL
-73,800
Closed -$8.19M

Similar funds

Gratus Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Gratus Capital held 187 positions worth $700M, up 0.8% from $695M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Gratus Capital's Q2 2017 filing shows 11 new, 47 increased, 46 reduced and 3 closed positions. Its largest new stake was AbbVie: 75,718 shares worth $5.49M. The largest sale was Schwab US REIT ETF, an estimated $8.43M.

By sector, the portfolio is most concentrated in Consumer Staples at 33% of assets, up from 32% a quarter earlier, followed by Industrials and Healthcare.

  • Gratus Capital's largest Q2 2017 buy was AbbVie: 75,718 shares worth $5.49M.
  • Gratus Capital added most to Intel in Q2 2017, an estimated $1.77M increase.
  • Gratus Capital's biggest Q2 2017 reduction was Schwab US REIT ETF, cutting an estimated $8.43M.
  • Gratus Capital fully exited Valspar in Q2 2017, selling an estimated $8.19M.
  • Gratus Capital's ten largest holdings make up 44% of its $700M portfolio in Q2 2017.
  • Gratus Capital opened 11 new positions and closed 3 in Q2 2017.
  • Gratus Capital's portfolio value rose 0.8% quarter-over-quarter to $700M.

Based on Gratus Capital's 13F filing for Q2 2017, filed 8 Aug 2017.